Subgroups in the treatment of nasal polyposis with dupilumab: A retrospective study

Dupilumab has been shown to be safe and effective in treating chronic rhinosinusitis with polyposis (CRSwNP). There is to this date no published data whether subgroups like patients with aspirin exacerbated respiratory disease (AERD), increased histologic eosinophilia or elevated blood eosinophil or...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertlich, Mattis, Freytag, Saskia, Dombrowski, Tobias, Jurmeister, Philipp, Spiegel, Jennifer Lee, Bertlich, Ines, Ihler, Friedrich, Weiss, Bernhard G., Haubner, Frank, Gröger, Moritz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
6000
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666224/
https://www.ncbi.nlm.nih.gov/pubmed/36397403
http://dx.doi.org/10.1097/MD.0000000000031031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666224/
https://www.ncbi.nlm.nih.gov/pubmed/36397403
http://dx.doi.org/10.1097/MD.0000000000031031

Ejemplares similares